{"id":"dc32109f-ffc7-53ff-9fa3-54934e7d1f8b","stable_key":"6660bba2-4fa0-590a-bf52-9803a24bea9f:dat-conformation","predicate":"reported_relationship","statement":"Mutational/modeling experiments support modafinil compatibility with DAT closed toward the extracellular side, not a permanently locked conformation in patients.","claim_class":"mechanistic","status":"source_recorded","evidence_grade":"ungraded","direction":"neutral","is_public":true,"mechanism_event_id":"1af6787b-f286-5b5a-9bb4-a8193ed9fada","mechanism_event_label":"Mutational/modeling experiments support modafinil compatibility with DAT closed toward the extracellular side, not a permanently locked conformation in patients.","subject":{"id":"624e6a4b-f96d-5d12-8206-30d1e1715c26","slug":"modafinil","display_name":"Modafinil","entity_type_key":"drug"},"object":{"id":"9e5c68df-f041-565a-8c77-b1282ff645eb","slug":"slc6a3","display_name":"Human dopamine transporter / DAT / SLC6A3","entity_type_key":"protein"},"evidence_count":1,"mechanism_event":{"id":"1af6787b-f286-5b5a-9bb4-a8193ed9fada","stable_key":"6660bba2-4fa0-590a-bf52-9803a24bea9f:dat-conformation-event","event_type":"biochemical_relationship","label":"Mutational/modeling experiments support modafinil compatibility with DAT closed toward the extracellular side, not a permanently locked conformation in patients.","description":"Mutational and modeling experiments distinguish modafinil from cocaine-like DAT inhibitors. The evidence supports greater compatibility with a transporter closed toward the extracellular side; it does not demonstrate a permanent, uniquely fixed conformation in patients. [2011 conformation study](https://pubmed.ncbi.nlm.nih.gov/22043293/)","status":"provisional","compartment":null,"participants":[{"entity":{"id":"624e6a4b-f96d-5d12-8206-30d1e1715c26","slug":"modafinil","display_name":"Modafinil","entity_type_key":"drug"},"role":"tested factor","stoichiometry":null,"state_label":"as reported","sequence_order":0,"notes":""},{"entity":{"id":"9e5c68df-f041-565a-8c77-b1282ff645eb","slug":"slc6a3","display_name":"Human dopamine transporter / DAT / SLC6A3","entity_type_key":"protein"},"role":"measured outcome","stoichiometry":null,"state_label":"not_reported","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_access","value_text":"Full XML obtained; relevant results/methods inspected. Not exhaustive reanalysis of figures or data.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Transporter mutation, ligand binding and modeling study.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"interpretation_status","value_text":"Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Mutational/modeling experiments support modafinil compatibility with DAT closed toward the extracellular side, not a permanently locked conformation in patients.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. | 2011 | DOI 10.1371/journal.pone.0025790 | PMID 22043293 | https://pmc.ncbi.nlm.nih.gov/articles/PMC3197159/ | https://pubmed.ncbi.nlm.nih.gov/22043293/","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"source_locator","value_text":"Reviewed reference lines 54-54; exact primary location described in quoted passage where extracted.","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"9f436c25-5e1a-54cb-b4bb-9bfeb56cff5f","evidence_kind":"source_excerpt","locator":"Lines 54-54","start_line":54,"end_line":54,"excerpt":"Mutational and modeling experiments distinguish modafinil from cocaine-like DAT inhibitors. The evidence supports greater compatibility with a transporter closed toward the extracellular side; it does not demonstrate a permanent, uniquely fixed conformation in patients. [2011 conformation study](https://pubmed.ncbi.nlm.nih.gov/22043293/)","model_system":"Transporter mutation, ligand binding and modeling study.","directness":"reported_statement","verification_status":"source_recorded","notes":"Exact excerpt of the retained AI-assisted reviewed reference; primary sources are cited in primary_references and access scope is retained. Not a verbatim quotation from a primary paper.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"17a64928-eaa2-5117-ba4f-52dcbdf9cc9e","stable_key":"import-6660bba2-4fa0-590a-bf52-9803a24bea9f","title":"Modafinil: detailed mechanisms of action (reviewed 3 October 2026)","document_type":"imported_text","citation_label":"Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication.","file_path":"","sha256":"006008cb4cfd183dd3b0846d3abc66c8ebf40cf1b6bd1f0bcdb4f4d937a8e115","revision_id":"c85b3e2e-c18a-59fc-9e79-5c375e64d119","review_status":"source_recorded","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}